Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ  Otavio Cabral-Marques,

Slides:



Advertisements
Similar presentations
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Advertisements

Maria B. Sukkar, PhD, Shaoping Xie, PhD, Nadia M
Multiple-checkpoint inhibition of thymic stromal lymphopoietin–induced TH2 response by TH17-related cytokines  Sofia I. Bogiatzi, BSc, Maude Guillot-Delost,
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Barbara Stanic, PhD, Willem van de Veen, PhD, Oliver F
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
Flow cytometry imaging identifies rare TH2 cells expressing thymic stromal lymphopoietin receptor in a “proallergic” milieu  Amanda J. Reefer, MS, Kathryn.
Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma  Chun-Yu Lo, MD, Charalambos Michaeloudes,
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production  Laura Maggi, PhD, Gianni Montaini, BSc, Alessio Mazzoni,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Autoimmune regulator (AIRE) contributes to Dectin-1–induced TNF-α production and complexes with caspase recruitment domain–containing protein 9 (CARD9),
Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy 
Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue  Jolien Suurmond, MSc, Kim L.L. Habets,
IgE cross-linking impairs monocyte antiviral responses and inhibits influenza-driven TH1 differentiation  Regina K. Rowe, MD, PhD, David M. Pyle, MD,
Sytze de Roock, PhD, Arie J
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival  Jyoti Balhara, MSc, Lianyu Shan,
Targeting Toll-like receptors on dendritic cells modifies the TH2 response to peanut allergens in vitro  Pierre Pochard, PhD, Brian Vickery, MD, M. Cecilia.
Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human β-defensin-3  Kevin O. Kisich, PhD, Charles.
Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis  Otavio Cabral Marques,
Glucocorticoids promote intrinsic human TH17 differentiation
Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen- specific T-cell tolerance in human tonsils and peripheral blood 
Dawn C. Newcomb, PhD, Madison G
Human dendritic cell subset 4 (DC4) correlates to a subset of CD14dim/−CD16++ monocytes  Federica Calzetti, BS, Nicola Tamassia, PhD, Alessandra Micheletti,
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
The innate antiviral response upregulates IL-13 receptor α2 in bronchial fibroblasts  Gemma Campbell-Harding, PhD, Hannah Sawkins, BSc, Nicole Bedke, PhD,
DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes  Roser Vento-Tormo, PhD, Damiana.
Jovana Maric, MSc, Avinash Ravindran, MSc, Luca Mazzurana, MSc, Åsa K
Miriam Wittmann, MD, Jana Zeitvogel, Dong Wang, MD, Thomas Werfel, MD 
Kathleen R. Bartemes, BA, Gail M. Kephart, BS, Stephanie J
Katherine G. MacDonald, BSc, Nicholas A. J
Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen- presenting cells that induce proallergic T cells  Susanne Ebner, PhD,
Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor–dependent innate antiviral immune responses  Douglas R. McDonald, MD, PhD,
Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype  Nicolas Gaudenzio, PhD, Camille Laurent, MD, Salvatore Valitutti,
Targeting Fel d 1 to FcγRI induces a novel variation of the TH2 response in subjects with cat allergy  Kathryn E. Hulse, BS, Amanda J. Reefer, MS, Victor.
Davide Pennino, MSc, Pankaj K
Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ  Otavio Cabral-Marques,
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid  Anne-Kathrin Kienzler, MSc, Marta Rizzi, MD,
Multiple-checkpoint inhibition of thymic stromal lymphopoietin–induced TH2 response by TH17-related cytokines  Sofia I. Bogiatzi, BSc, Maude Guillot-Delost,
Targeting allergen to FcγRI reveals a novel TH2 regulatory pathway linked to thymic stromal lymphopoietin receptor  Kathryn E. Hulse, PhD, Amanda J. Reefer,
A thymic stromal lymphopoietin–responsive dendritic cell subset mediates allergic responses in the upper airway mucosa  Guro R. Melum, MD, Lorant Farkas,
Chronic cat allergen exposure induces a TH2 cell–dependent IgG4 response related to low sensitization  Amedee Renand, PhD, Luis D. Archila, MSc, John.
Role of hyaluronan and hyaluronan-binding proteins in human asthma
β-Agonist enhances type 2 T-cell survival and accumulation
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus  Julie.
Jill A. Poole, MD, Neil E. Alexis, PhD, Conrad Parks, BS, Amy K
Mammalian target of rapamycin inhibition counterbalances the inflammatory status of immune cells in patients with chronic granulomatous disease  Aurélie.
The mannose receptor negatively modulates the Toll-like receptor 4–aryl hydrocarbon receptor–indoleamine 2,3-dioxygenase axis in dendritic cells affecting.
Staphylococcal exotoxins are strong inducers of IL-22: A potential role in atopic dermatitis  Margarete Niebuhr, MD, Helena Scharonow, MS, Merle Gathmann,
Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes  Rebeca Pérez de Diego, PhD, Eduardo López-Granados, MD, PhD,
Josée Lamoureux, PhD, Jana Stankova, PhD, Marek Rola-Pleszczynski, MD 
The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity 
Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells  Beatriz Abós-Gracia, BSc, Manuel.
Allergen-specific CD8+ T cells in peanut-allergic individuals
Amplification of Toll-like receptor–mediated signaling through spleen tyrosine kinase in human B-cell activation  Shigeru Iwata, MD, PhD, Kunihiro Yamaoka,
Matthew J. Loza, PhD, Susan Foster, PhD, Stephen P
Sara Paveglio, PhD, MS, Erin Bennett, MS, Kelly L. Hawley, PhD, Adam P
Phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity in patients with inherited IFN-γR1 or IFN-γR2 deficiency  Francesca Conti, MD,
The mannose receptor negatively modulates the Toll-like receptor 4–aryl hydrocarbon receptor–indoleamine 2,3-dioxygenase axis in dendritic cells affecting.
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Defective calcium signaling and disrupted CD20–B-cell receptor dissociation in patients with common variable immunodeficiency disorders  Annick A.J.M.
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X- linked–like syndrome, and defective IL-10 expression from CD4 lymphocytes 
IL-10–producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients  Antje Prasse, MD, Martin Germann,
Cigarette smoke exposure is associated with vitamin D3 deficiencies in patients with chronic rhinosinusitis  Jennifer K. Mulligan, PhD, Whitney Nagel,
Transforming growth factor β1 increases fibronectin deposition through integrin receptor α5β1 on human airway smooth muscle  Lyn M. Moir, PhD, Janette.
Intact IL-12 signaling is necessary for the generation of human natural killer cells with enhanced effector function after restimulation  Venkateswara.
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases  Francesca Scordamaglia, MD, Mirna Balsamo, PhD, Antonio Scordamaglia,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
CCL17/thymus and activation-regulated chemokine induces calcitonin gene–related peptide in human airway epithelial cells through CCR4  Kandace Bonner,
Presentation transcript:

Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-γ  Otavio Cabral-Marques, PhD, Rodrigo Nalio Ramos, PhD, Lena F. Schimke, MD, Taj Ali Khan, PhD, Eduardo Pinheiro Amaral, PhD, Caio César Barbosa Bomfim, MSc, Osvaldo Reis Junior, MSc, Tabata Takahashi França, MSc, Christina Arslanian, BSc, Joanna Darck Carola Correia Lima, MSc, Cristina Worm Weber, MD, Janaíra Fernandes Ferreira, MD, Fabiola Scancetti Tavares, MD, Jing Sun, MD, Maria Regina D'Imperio Lima, PhD, Marília Seelaender, PhD, Vera Lucia Garcia Calich, PhD, José Alexandre Marzagão Barbuto, MD, PhD, Beatriz Tavares Costa-Carvalho, MD, PhD, Gabriela Riemekasten, MD, Gisela Seminario, MD, Liliana Bezrodnik, MD, Luigi Notarangelo, MD, Troy R. Torgerson, MD, PhD, Hans D. Ochs, MD, Antonio Condino-Neto, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 3, Pages 900-912.e7 (March 2017) DOI: 10.1016/j.jaci.2016.07.018 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 rhIFN-γ, but not sCD40L, improves the defective fungicidal activity and oxidative burst of MDMs from CD40L-deficient patients. A, Cell morphology (top) was assessed by means of phase contrast (Axio Vert.A1) after 5 days in the presence of M-CSF. Flow cytometric analysis (bottom) was used to characterize expression of CD14, HLA-DR, CD64, CD163, and CD86 on the surfaces of MDMs. B, After challenging MDMs with P brasiliensis, fungicidal activity was assessed by determining CFU values. Before assay, MDMs were untreated (−) or treated with (+) sCD40L (500 ng/mL) or rhIFN-γ (100 U/mL) for 48 hours. CFU values (as percentages of control values) were determined in relation to the CFU number of untreated MDMs from healthy control subjects. The results in scatter plots and raw data in CFU per milliliter are shown in Fig E2. C, MDMs remained untreated or were cultured for 48 hours in the presence of sCD40L (500 ng/mL) or rhIFN-γ (100 U/mL); the respiratory burst of MDMs was induced by PMA (90 mmol/L). Cells were analyzed with the luminol-enhanced chemiluminescence assay, and values are expressed as relative light units (RLU). A significant difference is denoted as follows: *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Impaired cytokine production by macrophages from CD40L-deficient patients. Patients' macrophages secrete abnormal levels of IL-6, TNF-α, IL-1β, macrophage inflammatory protein 1β [MIP-1β], IP-10, and G-CSF in response to M tuberculosis and P brasiliensis. After 48 hours of sCD40L (500 ng/mL) or rhIFN-γ (100 U/mL) treatment, cytokine production by patients' macrophages achieved a pattern similar to that observed in healthy control subjects. Significant differences are denoted as follows: *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Defective control of the proliferation of M tuberculosis by MDMs from CD40L-deficient patients is improved by rhIFN-γ. A, Macrophages were challenged with M tuberculosis (H37Rv strain), and the phagocytosis index was determined on day 0 based on CFU counts. B, The bacterial proliferation index on day 6 was determined based on the ratio of CFU numbers on day 6 to CFU numbers on day 0. Data were normalized according to the average mycobacterial growth of untreated MDMs from healthy control subjects. Significant differences are denoted as follows: *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Hierarchical cluster analysis showing MDM gene signature in patients with CD40L deficiency and the subsequent effects of IFN-γ. A, RNA from MDMs was sequenced, and the transcripts per million (TPM) values are represented on a log2 scale, where green shows low expression and red shows high expression. The results of untreated (left panel) and rhIFN-γ–treated (right panel) cells are shown in the heat map. B, Interaction networks for the DEGs in CD40L deficiency are shown. Networks are shown as predicted by GeneMania and visualized with Cytoscape. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Heat map of genes not dysregulated in patients with CD40L deficiency but affected by rhIFN-γ treatment. Results for untreated and rhIFN-γ–treated cells are shown in the heat map. RNA from MDMs were sequenced, and the transcripts per million (TPM) values are represented on a log2 scale, where green shows low expression and red shows high expression. Genes significantly upregulated or downregulated are listed. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Effect of rhIFN-γ on expression of CD40, TLRs, and CLRs by macrophages. Representative histograms (A) and graphics (B) showing CD40, TLR (TLR1, TLR2, and TLR4), and CLR (dectin-1, dectin-3, mannose receptor or MR, DEC-205, and CD209) expression, as analyzed by means of cytometry. MDMs were analyzed after 5 days in the presence of M-CFS, followed by 2 additional days in the presence or absence of rhIFN-γ. No significant differences in MDMs from patients versus healthy subjects were observed. *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. NS, Not significant; MFI, Mean fluorescence intensity. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 rhIFN-γ, but not sCD40L, improves the defective fungicidal activity seen in CD40L-deficient patients. A, After challenging MDMs with P brasiliensis, fungicidal activity was assessed by determining CFU values. Before assay, MDMs were either untreated (−) or treated with (+) sCD40L (500 ng/mL) or rhIFN-γ (100 U/mL) for 48 hours. CFU values (percentage of control values) were determined in relation to the CFU number of untreated MDMs from healthy control subjects. B, Raw data in CFU/mL are also shown. Significant differences are denoted as follows: *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 M-CSF does not induce CD40L expression on monocytes/macrophages. Expression of CD40L, CD69, and CD163 on MDMs was analyzed by means of flow cytometry on each day of macrophage differentiation. No expression of CD40L and CD69 on MDMs was observed. On the other hand, CD163 expression was increased in the presence of M-CSF. MFI, Mean fluorescence intensity. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 sCD40L increases the capacity of the promyelocytic HL-60 cells to control M tuberculosis proliferation. Promyelocytic HL-60 cells, which express CD40 (left panel), were cultivated in the absence presence of sCD40L (500 ng/mL), and their ability to control M tuberculosis proliferation was analyzed by CFU (right panel). *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Normal expression of CD86, CD206, and CD163 on macrophages from CD40L-deficient patients. MDMs were cultured in the presence of IL-4 or IFN-γ alone or in concert with M tuberculosis. Expression of CD86 (A), CD163 (B), and CD206 (C) was analyzed by using flow cytometry, and data were represented as mean fluorescence intensity (MFI). *P ≤ .05 (n = 6 patients and 6 control subjects), Mann-Whitney test. NS, Not significant. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E5 The IFN-γ/IL-12 axis is normally activated by rhIFN-γ and rhIL-12. A, PBMCs were activated for 48 hours in the presence of rhIFN-γ (100 U/mL) to induce IL-12 production. B, Cells were stimulated with rhIL-12 (10 ng/mL) for 48 hours to analyze IFN-γ production. Supernatants were harvested and analyzed by means of ELISA. Journal of Allergy and Clinical Immunology 2017 139, 900-912.e7DOI: (10.1016/j.jaci.2016.07.018) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions